What is the share price of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) today?
The share price of DRAGARWQ as on 17th July 2025 is ₹4451.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) share?
The past returns of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) share are- Past 1 week: -0.69%
- Past 1 month: -0.11%
- Past 3 months: 8.31%
- Past 6 months: -35.82%
- Past 1 year: 34.47%
- Past 3 years: 585.95%
- Past 5 years: 1897.22%
What are the peers or stocks similar to Dr Agarwal's Eye Hospital Ltd (DRAGARWQ)?
The peers or stocks similar to Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) include:What is the dividend yield % of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) share?
The current dividend yield of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) is 0.13.What is the market cap of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) is ₹2092.56 Cr as of 17th July 2025.What is the 52 week high and low of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) share?
The 52-week high of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) is ₹7300 and the 52-week low is ₹3299.80.What is the PE and PB ratio of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) stock?
The P/E (price-to-earnings) ratio of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) is 38.29. The P/B (price-to-book) ratio is 13.32.Which sector does Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) belong to?
Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) shares?
You can directly buy Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Dr Agarwal's Eye Hospital Ltd
DRAGARWQ Share Price
4,451.250.02% (+1.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
DRAGARWQ Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
DRAGARWQ Performance & Key Metrics
DRAGARWQ Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 38.29 | 13.32 | 0.13% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.40 | 6.48 | 0.81% |
DRAGARWQ Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
DRAGARWQ Company Profile
Dr. Agarwal's Eye Hospital Limited is an eye care company that provides nursing homes; clinics; medical, research and other institutions and establishments for eye care and treatment, and other healthcare facilities.
MAXHEALTH
PE Ratio
114.41
114.41
1Y Return
33.07%
33.07%
Buy Reco %
75.00
75.00
APOLLOHOSP
PE Ratio
73.12
73.12
1Y Return
12.72%
12.72%
Buy Reco %
89.66
89.66
FORTIS
PE Ratio
77.54
77.54
1Y Return
65.97%
65.97%
Buy Reco %
92.86
92.86
PE Ratio
50.16
50.16
1Y Return
57.86%
57.86%
Buy Reco %
70.00
70.00
MEDANTA
PE Ratio
74.72
74.72
1Y Return
11.71%
11.71%
Buy Reco %
71.43
71.43
DRAGARWQ Forecast
DRAGARWQ Forecasts
Price
Revenue
Earnings
DRAGARWQ Share Price Forecast
DRAGARWQ Share Price Forecast
2025
Current
₹4,451.80
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹4,451.80
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
DRAGARWQ
DRAGARWQ
Income
Balance Sheet
Cash Flow
Annual Normal View
DRAGARWQ Income Statement
DRAGARWQ Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 150.19 | 155.62 | 172.03 | 178.60 | 140.62 | 202.47 | 269.65 | 324.27 | 402.24 | 402.24 | ||||||||||
Raw Materials | 17.52 | 18.96 | 18.23 | 22.59 | 15.08 | 23.67 | 30.68 | 35.95 | 278.65 | 278.65 | ||||||||||
| Power & Fuel Cost | 3.08 | 2.88 | 3.30 | 2.53 | 2.10 | 2.66 | 3.40 | 5.74 | ||||||||||||
| Employee Cost | 32.49 | 31.98 | 33.77 | 35.63 | 32.17 | 38.51 | 53.26 | 63.78 | ||||||||||||
| Selling & Administrative Expenses | 28.47 | 31.46 | 56.83 | 43.00 | 32.49 | 43.24 | 60.46 | 73.59 | ||||||||||||
| Operating & Other expenses | 44.77 | 43.79 | 27.94 | 25.09 | 26.98 | 34.48 | 44.23 | 48.05 | ||||||||||||
EBITDA | 23.86 | 26.55 | 31.96 | 49.76 | 31.80 | 59.91 | 77.62 | 97.16 | 123.59 | 123.59 | ||||||||||
| Depreciation/Amortization | 8.74 | 9.78 | 10.91 | 21.24 | 19.10 | 20.39 | 20.18 | 26.61 | 39.45 | 39.45 | ||||||||||
| PBIT | 15.12 | 16.77 | 21.05 | 28.52 | 12.70 | 39.52 | 57.44 | 70.55 | 84.14 | 84.14 | ||||||||||
| Interest & Other Items | 4.16 | 3.41 | 3.62 | 8.59 | 6.96 | 7.21 | 8.04 | 8.30 | 13.44 | 13.44 | ||||||||||
| PBT | 10.96 | 13.36 | 17.43 | 19.93 | 5.74 | 32.31 | 49.40 | 62.25 | 70.70 | 70.70 | ||||||||||
| Taxes & Other Items | 3.64 | 6.58 | 5.51 | 6.26 | 7.18 | 8.21 | 12.48 | 15.89 | 16.05 | 16.05 | ||||||||||
| Net Income | 7.32 | 6.78 | 11.92 | 13.67 | -1.44 | 24.10 | 36.92 | 46.36 | 54.65 | 54.65 | ||||||||||
| EPS | 15.57 | 14.43 | 25.36 | 29.09 | -3.06 | 51.28 | 78.55 | 98.64 | 116.28 | 116.28 | ||||||||||
| DPS | 1.50 | 1.20 | 1.50 | 0.00 | 0.00 | 3.00 | 3.00 | 2.50 | 6.00 | 5.00 | ||||||||||
| Payout ratio | 0.10 | 0.08 | 0.06 | 0.00 | 0.00 | 0.06 | 0.04 | 0.03 | 0.05 | 0.04 |
DRAGARWQ Company Updates
DRAGARWQ Stock Peers
DRAGARWQ Past Performance & Peer Comparison
DRAGARWQ Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation-basic on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dr Agarwal's Eye Hospital Ltd | 38.29 | 13.32 | 0.13% |
| Max Healthcare Institute Ltd | 114.41 | 13.12 | 0.12% |
| Apollo Hospitals Enterprise Ltd | 73.12 | 14.44 | 0.38% |
| Fortis Healthcare Ltd | 77.54 | 6.55 | 0.13% |
DRAGARWQ Stock Price Comparison
Compare DRAGARWQ with any stock or ETFCompare DRAGARWQ with any stock or ETF
DRAGARWQ
DRAGARWQ Holdings
DRAGARWQ Shareholdings
DRAGARWQ Promoter Holdings Trend
DRAGARWQ Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
Lower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
DRAGARWQ Institutional Holdings Trend
DRAGARWQ Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
DRAGARWQ Shareholding Pattern
DRAGARWQ Shareholding Pattern
DRAGARWQ Shareholding History
DRAGARWQ Shareholding History
Foreign Institutions
Mutual Funds Invested in DRAGARWQ
Mutual Funds Invested in DRAGARWQ
No mutual funds holding trends are available
Top 3 Mutual Funds holding Dr Agarwal's Eye Hospital Ltd
| Funds (Top 3) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1080% | Percentage of the fund’s portfolio invested in the stock 0.62% | Change in the portfolio weight of the stock over the last 3 months 0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 34/66 (+6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0124% | Percentage of the fund’s portfolio invested in the stock 0.23% | Change in the portfolio weight of the stock over the last 3 months 0.23% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 32/32 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0094% | Percentage of the fund’s portfolio invested in the stock 0.22% | Change in the portfolio weight of the stock over the last 3 months 0.22% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 83/83 (-1) |
Compare 3-month MF holding change on Screener
smallcases containing DRAGARWQ stock
smallcases containing DRAGARWQ stock
Looks like this stock is not in any smallcase yet.
DRAGARWQ Events
DRAGARWQ Events
DRAGARWQ Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
DRAGARWQ Dividend Trend
No dividend trend available
DRAGARWQ Upcoming Dividends
DRAGARWQ Upcoming Dividends
No upcoming dividends are available
DRAGARWQ Past Dividends
DRAGARWQ Past Dividends
Cash Dividend
Ex DateEx DateNov 8, 2024
Interim
Interim | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Nov 8, 2024
Cash Dividend
Ex DateEx DateAug 19, 2024
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Aug 19, 2024
Cash Dividend
Ex DateEx DateOct 31, 2023
Interim
Interim | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Oct 31, 2023
Cash Dividend
Ex DateEx DateSep 14, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 14, 2023
Cash Dividend
Ex DateEx DateSep 6, 2022
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 6, 2022
DRAGARWQ Stock News & Opinions
DRAGARWQ Stock News & Opinions
Articles & Videos
Corporate
Board of Dr Agarwals Eye Hospital recommends final dividend
Dr Agarwals Eye Hospital announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 3.5 per equity Share (i.e. 35%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Dr Agarwal's Eye Hospital standalone net profit rises 25.02% in the March 2025 quarter
Net profit of Dr Agarwal's Eye Hospital rose 25.02% to Rs 15.99 crore in the quarter ended March 2025 as against Rs 12.79 crore during the previous quarter ended March 2024. Sales rose 23.67% to Rs 99.83 crore in the quarter ended March 2025 as against Rs 80.72 crore during the previous quarter ended March 2024. For the full year,net profit rose 17.88% to Rs 54.65 crore in the year ended March 2025 as against Rs 46.36 crore during the previous year ended March 2024. Sales rose 24.38% to Rs 397.15 crore in the year ended March 2025 as against Rs 319.30 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales99.8380.72 24 397.15319.30 24 OPM %31.6430.28 -29.8428.52 - PBDT28.8024.87 16 110.1588.86 24 PBT18.6017.34 7 70.7062.25 14 NP15.9912.79 25 54.6546.36 18 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Dr Agarwals Eye Hospital to conduct board meeting
Dr Agarwals Eye Hospital will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Dr Agarwal's Eye Hospital standalone net profit rises 10.17% in the December 2024 quarter
Net profit of Dr Agarwal's Eye Hospital rose 10.17% to Rs 10.40 crore in the quarter ended December 2024 as against Rs 9.44 crore during the previous quarter ended December 2023. Sales rose 25.23% to Rs 95.11 crore in the quarter ended December 2024 as against Rs 75.95 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales95.1175.95 25 OPM %26.9427.35 - PBDT24.0819.61 23 PBT14.0612.72 11 NP10.409.44 10 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Dr Agarwals Eye Hospital to hold board meeting
Dr Agarwals Eye Hospital will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Spotlight
Dr Agarwals Eye Hospital Ltd leads losers in 'B' group
Godavari Biorefineries Ltd, Inventurus Knowledge Solutions Ltd, Jagsonpal Pharmaceuticals Ltd and Selan Explorations Technology Ltd are among the other losers in the BSE's 'B' group today, 27 January 2025.Dr Agarwals Eye Hospital Ltd tumbled 17.06% to Rs 4984 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 18301 shares were traded on the counter so far as against the average daily volumes of 5897 shares in the past one month.Godavari Biorefineries Ltd crashed 14.33% to Rs 224.5. The stock was the second biggest loser in 'B' group.On the BSE, 58971 shares were traded on the counter so far as against the average daily volumes of 11970 shares in the past one month.Inventurus Knowledge Solutions Ltd lost 13.13% to Rs 1548. The stock was the third biggest loser in 'B' group.On the BSE, 17947 shares were traded on the counter so far as against the average daily volumes of 17452 shares in the past one month.Jagsonpal Pharmaceuticals Ltd plummeted 12.92% to Rs 213. The stock was the fourth biggest loser in 'B' group.On the BSE, 46831 shares were traded on the counter so far as against the average daily volumes of 28541 shares in the past one month.Selan Explorations Technology Ltd slipped 12.55% to Rs 616.7. The stock was the fifth biggest loser in 'B' group.On the BSE, 23626 shares were traded on the counter so far as against the average daily volumes of 3183 shares in the past one month.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Dr Agarwals Eye Hospital fixes record date for Dividend
Dr Agarwals Eye Hospital has fixed 8th November 2024 as the record date for the purpose of interim dividend.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Board of Dr Agarwals Eye Hospital recommends Interim dividend
Dr Agarwals Eye Hospital announced that the Board of Directors of the Company at its meeting held on 29 October 2024, inter alia, have recommended the Interim dividend of Rs 2.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Dr Agarwal's Eye Hospital standalone net profit rises 12.39% in the September 2024 quarter
Net profit of Dr Agarwal's Eye Hospital rose 12.39% to Rs 14.15 crore in the quarter ended September 2024 as against Rs 12.59 crore during the previous quarter ended September 2023. Sales rose 21.52% to Rs 102.19 crore in the quarter ended September 2024 as against Rs 84.09 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales102.1984.09 22 OPM %29.2427.60 - PBDT28.4922.99 24 PBT19.1316.65 15 NP14.1512.59 12 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Dr Agarwals Eye Hospital declare Quarterly Result
Dr Agarwals Eye Hospital will hold a meeting of the Board of Directors of the Company on 29 October 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.63%, vs industry avg of 12.95%
Over the last 5 years, market share increased from 0.42% to 0.51%
Over the last 5 years, net income has grown at a yearly rate of 31.94%, vs industry avg of 41.11%